Combined Effects of Inspiratory Muscles Training With Pilate Training in Asthma Patients
1 other identifier
interventional
52
1 country
1
Brief Summary
Asthma is a chronic (long-term) condition that affects the airways in the lungs. The airways are tubes that carry air in and out of your lungs. In asthma the airways can become inflamed and narrowed at times. This makes it harder for air to flow out of your airways when you breathe out. When symptoms get worse, it is called an asthma attack. There is no permeant cure for asthma, but medical treatment and physiotherapy treatment can help to manage it. There is many physiotherapy protocols can be used for asthma patients like aerobic exercises, breathing exercise etc. The objective of our study is determine the combine effects of inspiratory muscle training with Pilate training on dyspnea, cardiorespiratory fitness and quality of life in asthma patients. The randomized control trial will used as study design as study design for this this purpose simple random sampling technique will be used to allocate the sample in two group The sample size will be calculated by the G-power analysis. This study will conduct in Jinnah Hospital, Lahore Group A will receive both inspiratory training and Pilate training and group B receive only Inspiratory training, incentive spirometer the participants were instructed to hold the breath for 2-3 seconds then exhale slowly. This process was repeated 10 times or about 10-15minutes with rest in between 30 seconds. Base line treatment is diaphragmatic breathing exercise .The session will repeated three times per week for 6 weeks with 40-minute sessions In Pilates we include 5 Pilate exercise, The Hundred (Rhythmic Breathing), Single Leg Stretch (Rhythmic Breathing), side kick, Toe Taps (Set Breathing Pattern) ,leg pull front. Pre and post measurement will be done using Juniper asthma quality of life, 6 mint walk test, Borges dyspnea scale and fatigue severity scale to measure the outcomes. Data will be analyzed SPSS version 25. T-test and Regression analysis will be used. Key words: asthma patient, cardiorespiratory fitness, dyspnea, quality of life, Pilate training, inspiratory muscle training
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable asthma
Started Apr 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 20, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2024
CompletedFirst Submitted
Initial submission to the registry
January 1, 2025
CompletedFirst Posted
Study publicly available on registry
January 7, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2025
CompletedJanuary 7, 2025
January 1, 2025
8 months
January 1, 2025
January 1, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
SF 36
A disease-specific health-related quality of life instrument developed by E. Juniper in1999and colleagues that taps both physical and emotional impact of disease. The instrument should not be confused with the measure developed by Marks and colleagues, which carries the same name. Asthma Quality of Life Questionnaire (AQLQ or AQLQ-J) developed by Juniper and colleagues is a 32 questions instrument to measure the functional problems that are most troublesome to adults. Symptoms (11 items), Activity Limitation (12 items, 5 of which are individualized), Emotional Function (5 items), and Environmental Exposure (4 items) Scaling of items 7-point Likert scale Scoring All items are weighted equally. Mean score is calculated across all items within each domain. Overall score is the mean across all items
8 weeks
6MWT
The 6MWT is a sub-maximal exercise test used to examine person aerobic capacity and endurance. This test initially developed to make an assessment of patient with cardiopulmonary issues. It is used to check the functional capacity of the individual and it provides useful information regarding all the body systems during physical activity, including cardiovascular and pulmonary system. It can used for all age group range 2 to above 64 years The test is easy to perfume , with standardized limited instructions and encouragement being given as person walk as far as possible over 6 minutes through a flat corridor. The final distance is recorded in meters6
8 weeks
Study Arms (2)
Treatment Group
EXPERIMENTAL.The session will repeated three times per week for 6 weeks with 40-minute sessions In Pilates we include 5 Pilate exercise, The Hundred (Rhythmic Breathing), Single Leg Stretch (Rhythmic Breathing), side kick, Toe Taps (Set Breathing Pattern) ,leg pull front for 6 weeks.
Controlied Group
PLACEBO COMPARATORInspiratory training, incentive spirometer the participants were instructed to hold the breath for 2-3 seconds then exhale slowly. This process was repeated 10 times or about 10-15minutes with rest in between 30 seconds. Base line treatment is diaphragmatic breathing exercise
Interventions
.The session will repeated three times per week for 6 weeks with 40-minute sessions In Pilates we include 5 Pilate exercise, The Hundred (Rhythmic Breathing), Single Leg Stretch (Rhythmic Breathing), side kick, Toe Taps (Set Breathing Pattern) ,leg pull front for 6 weeks.
Eligibility Criteria
You may qualify if:
- Age range from 30 to 50 (15)
- Both Male and Female
- FEV1 value range from 64% to less than 50%
- Medically cleared for cardiac rehabilitation.
- Medical treatment, for at least 6 months
- Clinically stable (i.e., no exacerbation or medication changes for at least 30 days.
You may not qualify if:
- Status Asthmatics
- Patient with cardiac disease
- Age range from 30 to 50 (15)
- Both Male and Female
- FEV1 value range from 64% to less than 50%
- Medically cleared for cardiac rehabilitation.
- Medical treatment, for at least 6 months
- Clinically stable (i.e., no exacerbation or medication changes for at least 30 days.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gulab Devi Hospital
Lahore, Punjab Province, 05307, Pakistan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sumera Hameed, Mphill
Riphah International University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 1, 2025
First Posted
January 7, 2025
Study Start
April 20, 2024
Primary Completion
December 30, 2024
Study Completion
April 30, 2025
Last Updated
January 7, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share